Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers

European Journal of Nuclear Medicine

Volumn 27, Issue 7, 2000, Pages 867-869

  Lavalaye, Jules ^a,b   Booij, Jan ^a   Reneman, Liesbeth ^a   Habraken, Jan B A ^a   Van Royen, Eric A ^a  

^a Amsterdam University Medical Center   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Age; Dopamine transporter imaging; Gender; Single photon emission tomography; 123I FP CIT

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123; TROPANE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; NORMAL HUMAN; RECEPTOR DENSITY; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033933435     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000279     Document Type: Article

References (10)

1. 1. van Dyck CH, Seibyl JP, Malison RT, et al. Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT. J Nucl Med 1995; 36: 1175-1181.
2. 2. Mozley PD, Acton PD, Barraclough ED, et al. Effects of age on dopamine transporters in healthy humans. J Nucl Med 1999; 40: 1812-1817.
3. 3. Volkow ND, Ding YS, Fowler JS, et al. Dopamine transporters decrease with age. J Nucl Med 1996; 37: 554-559.
4. 4. Kuikka JT, Tupala E, Bergström KA, et al. Iodine-123 labelled PE2I for dopamine transporter imaging: influence of age in healthy subjects. Eur J Nucl Med 1999; 26: 1486-1488.
5. 5. Tissingh G, Booij J, Bergmans P, et al. Iodine-123-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 1998; 39: 1143-1148.
6. 6. Kuikka JT, Tiihonen J, Karhu J, et al. Fractal analysis of striatal dopamine re-uptake sites. Eur J Nucl Med 1997; 24: 1085-1090.
7. 7. Rivest R, Falardeau P, Di Paolo T. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 1995; 692: 269-272.
8. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 133-140.
9. 9. Habraken JBA, Booij J, Slomka P, et al. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med 1999; 40: 1091-1097.
10. 2 receptor binding characteristics in vivo. Am J Psychiatry 1998; 155: 768-773.